Transcatheter Aortic Valve replacement: Design, clinical Application, and Future challenges

Yale Journal of Biology and Medicine

Volumn 85, Issue 2, 2012, Pages 239-247

  Forrest, John K ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Edwards Sapien Valve; Medtronic CoreValve; TAVI; TAVR; Transcatheter aortic valve replacement

Indexed keywords

AORTA STENOSIS; DEVICE APPROVAL; DISEASE ASSOCIATION; DISEASE SEVERITY; EQUIPMENT DESIGN; HIGH RISK PATIENT; HISTORY OF MEDICINE; HUMAN; INTERMETHOD COMPARISON; OUTCOME ASSESSMENT; PRODUCT DEVELOPMENT; REVIEW; RISK ASSESSMENT; SURGICAL MORTALITY; SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT INDICATION; AORTA VALVE PROSTHESIS; AORTIC VALVE REPAIR; ARTICLE; BIOMEDICAL ENGINEERING; CLINICAL EFFECTIVENESS; FOOD AND DRUG ADMINISTRATION; NONHUMAN; POSTOPERATIVE HEMORRHAGE; PROCESS DEVELOPMENT; QUALITY OF LIFE;

AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; FORECASTING; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

NITINOL;

EID: 84863433135     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Leon MB, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597-607.
2. Iung B, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231-43.
3. Stewart BF, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29(3):630-4.
4. Ross J Jr., Braunwald E. Aortic stenosis. Circulation. 1968;38(1 Suppl):61-7.
5. Otto CM. Timing of aortic valve surgery. Heart. 2000;84(2):211-8.
6. Gardin JM, et al. Aortic stenosis: can severity be reliably estimated noninvasively? Chest. 1980;77(2):130-1.
7. Iung B, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26(24):2714-20.
8. Bouma BJ, et al. Variability in treatment advice for elderly patients with aortic stenosis: a nationwide survey in The Netherlands. Heart. 2001;85(2):196-201.
9. Pellikka PA, Sundt TM. Management of asymptomatic severe aortic stenosis: is aortic valve replacement indicated? Nat Clin Pract Cardiovasc Med. 2008;5(10):608-9.
10. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J. 1992;13(5):704-8.
11. Cribier A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106(24):3006-8.
12. Smith CR, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187-98.
13. Webb J, Cribier A. Percutaneous transarterial aortic valve implantation: what do we know? Eur Heart J. 2011;32(2):140-7.
14. Vahanian A, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2008;29(11):1463-70.
15. The Edwards SAPIEN THV Transcatheter Heart Valve System for Patients With Severe Aortic Stenosis Who Are Not Candidates for Conventional Open-Heart Aortic Valve Replacement Surgery. Briefing Document for the FDA Circulatory Systems Device Panel Advisory Committee [Internet]. 2011 July 20. Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/UCM262935.pdf
16. Liao K, et al. Bovine pericardium versus porcine aortic valve: comparison of tissue biological properties as prosthetic valves. Artif Organs. 1992;16(4):361-5.
17. Metallurgy: The Alloy That Remembers. TIME Magazine. 1968 Sept 13.
18. Ussia GP, et al. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur Heart J. Epub 2012 Jan 12.
19. Calvi V, et al. Incidence rate and predictors of permanent pacemaker implantation after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis. J Interv Card Electrophysiol. Epub 2011 Nov 25.
20. Calvi V, et al. Early conduction disorders following percutaneous aortic valve replacement. Pacing Clin Electrophysiol. 2009;32(Suppl 1):S126-30.
21. Jilaihawi H, et al. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart J. 2009;157(5):860-6.
22. Piazza N, et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv. 2008;1(3):310-6.
23. O'Riordan M. STACCATO: Transapical TAVI in surgery-eligible patients stopped due to adverse events [Internet]. 2011 Nov 10. Available from: http://www.theheart.org/article/1307437.do.
24. Holmes DR Jr., et al. 2012 ACCF/AATS/SCAI/STS Expert Consensus Document on Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2012;59(13):1200-54.